In this webinar we will describe the clinical indications and the benefits of diabetes technology (eg, insulin pumps and CGM) in the management of type 1 and type 2 diabetes. We will also discuss differences in diabetes technology used in certain populations with diabetes and the potential drivers of these differences. Lastly, we will discuss approaches to promote more equitable use of diabetes technology across all populations with diabetes.
Sign in to take quiz and track your certificates
Endocrine Society is a global community of physicians and scientists energized by the promise of unraveling the mysteries of hormone disorders to care for patients and cure disease.
To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.
© 2023 Copyright Endocrine Society. All rights reserved.
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's peer reviewers.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The faculty reported the following rehas reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.levant financial relationship(s) during the content development process for this activity:
The following faculty reported no relevant financial relationships: Larissa Gomes, MD; Estelle Everett, MD, MHS; Ro Pereira, MD
The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
Accreditation Widget language: (only highlighted sections can be edited)
Accreditation Statement: The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement: The Endocrine Society designates this Enduring Material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation Statement: The Endocrine Society designates this Enduring Material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You currently have no searches saved.
You currently have no courses saved.